Trends and results for organ donation and transplantation in the United States, 2004

American Journal of Transplantation

Volumn 5, Issue 4 II, 2005, Pages 843-849

  Port, Friedrich K ^a   Dykstra, Dawn M ^a   Merion, Robert M ^b   Wolfe, Robert A ^b  

^a Univ Ren Res and Educ Assoc   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Allocation policy; OPTN; Organ donation; SRTR; Transplantation; Transplantation outcomes; Waiting list

Indexed keywords

ALEMTUZUMAB; ANTIMETABOLITE; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

CADAVER DONOR; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG TRANSPLANTATION; MEDICAL RESEARCH; MORTALITY; ORGAN DONOR; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

EID: 16244401628     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6135.2005.00831.x     Document Type: Review

References (0)